AI Fertility Advisor: Evidence-Based IVF Cycle Guidance
2026-09-05
Fertility & IVF Advisor helps you make sense of labs, protocols, and clinic recommendations so you can walk into every appointment prepared. While fertility care is fragmented across portals, printouts, and late-night searches, this AI provides personalized, evidence-based analysis across conception attempts, workups, IUI, IVF, preservation, and alternative family-building paths.
✅ Interprets AMH, AFC, semen analysis, and monitoring data in the context of your age and diagnosis ✅ Evaluates protocols, add-ons, and clinic advice against current professional-society evidence ✅ Prepares focused questions for reproductive endocrinology visits ✅ Remembers your history across cycles so you are not starting from zero each time
It is not a physician and does not replace your care team. It is the informed second set of eyes most people wish they had when a decision is expensive, time-sensitive, and deeply personal.
To understand why that matters, it helps to look at what patients are actually asked to navigate — medically, financially, and emotionally — before they ever get a clear plan.
Quick Answer: What Is Fertility & IVF Advisor?
Fertility & IVF Advisor is an AI fertility companion that interprets labs, protocols, and clinic recommendations to help you make informed treatment decisions. It learns your reproductive history over time and supplements — never replaces — care from a licensed clinician.
Key capabilities:
- Contextual interpretation of ovarian reserve, semen analysis, and IVF monitoring
- Protocol comparison (antagonist, flare, mini-IVF, DuoStim, freeze-all vs. fresh)
- Evidence review of add-ons such as PGT-A, embryo glue, and immunological treatments
- Appointment prep, medication frameworks, and financial questions to ask your clinic
- Support through the two-week wait, failed cycles, and path changes including donor gametes
Why Fertility Decisions Feel So Hard to Navigate
Infertility is recognized as a disease by the World Health Organization and the American Medical Association. Treatment, however, is still delivered in short visits, billed in fragments, and explained in language that assumes you already know what AMH, TMC, and a 4AB blastocyst mean.
The money alone would make any major medical decision harder:
$19,200 — Median U.S. price of one IVF cycle, including medications
~50% of annual disposable income — What a single cycle can represent for an average person
83% — Share of fertility patients in one industry survey who were concerned or very concerned about cost
Access is uneven as well. ASRM has noted that an estimated 18 million women of reproductive age live in locations with no ART clinic, and Stanford researchers have documented how infertility’s private and public costs extend well beyond the invoice. Time is a hidden tax: monitoring visits, retrievals, and transfers consume workdays that research on the time costs of fertility care has described as a distinct hardship of building a family this way.
National CDC ART surveillance publishes clinic-level success data, but those reports do not interpret your AMH, your lining, or your last failed transfer. Clinic portals store numbers. They rarely explain what a day-3 FSH of 12 means when estradiol is already elevated, or whether a third IUI is still a reasonable use of time at 38.
But getting clear, current, personalized analysis is frustratingly difficult:
- Results without context. AMH predicts stimulation response (quantity), not egg quality. A value that is concerning at 28 can be expected at 42 — yet the lab report will not say that.
- Add-ons sold as essentials. Clinics often offer extra procedures whose benefit is unproven for most patients.
- Protocol jargon under time pressure. Antagonist vs. microdose flare, agonist trigger vs. hCG, freeze-all vs. fresh — these choices have real OHSS, cost, and success implications, and they are often made in a 15-minute slot.
- No memory between cycles. Each new nurse, portal, or search tab treats you as a first-time patient, even if you already have three stim calendars and a stack of betas.
The UK regulator has been unusually direct about the add-on problem. The HFEA’s treatment add-ons ratings exist because many optional extras lack strong evidence of improving the chance of a baby. In a 2026 statement, the HFEA noted that most add-ons offer no proven benefit. Its patient guidance is practical: if you are paying out of pocket, additional proven IVF or IUI cycles may be a better use of money than unproven extras on a single cycle.
PGT-A illustrates the same pattern at larger scale. Use in U.S. IVF rose from 14% of cycles in 2014 to 44% in 2019, even as ASRM concluded that PGT-A has not been shown to be a universal screening test for all IVF patients. One large randomized trial found cumulative live births of 77.2% with PGT-A versus 81.8% with conventional IVF in a younger, favorable-prognosis group. Per-transfer implantation can look better — especially at older ages in SART observational data — without guaranteeing a higher cumulative live-birth rate. That distinction is easy to miss in a consult.
This is exactly the gap a dedicated fertility advisor was built to fill: not to override your RE, but to help you understand the evidence before you say yes.
How It Works: From First Labs to the Next Decision
You do not need a perfect file of records to start. You need the question that is keeping you up, and as much history as you have.
Step 1: Describe Where You Are in the Journey
Share age, how long you have been trying, known diagnoses, partner or donor situation, and what your clinic just recommended. Region matters too, because insurance mandates, HFEA vs. SART reporting, and surrogacy law are not universal. The more specific you are, the more specific the analysis.
"I'm 37, AMH 0.9 ng/mL, AFC 7. Partner's TMC is 18 million. Clinic wants three medicated IUIs before IVF. We've been trying for 8 months. Does that sequence match current evidence for my age?"
Step 2: Put Numbers in Clinical Context
Upload or paste AMH, day-3 FSH/estradiol, AFC, HSG notes, or a semen analysis. The fertility advisor treats one value as a snapshot, not a verdict. It will flag when a high day-3 estradiol is masking FSH, when a single abnormal semen analysis needs a repeat, and when ovarian reserve markers are being over-read as egg-quality scores.
If you also keep thyroid panels, imaging, or a longer health record across other conditions, Personal Medical Analyst can help organize that broader file so fertility decisions sit on top of a coherent medical history rather than a folder of PDFs.
"Here is my AMH of 1.1, day-3 FSH 11.4, estradiol 82, and last semen analysis. What does this combination actually mean for stimulation response versus natural conception odds?"
Step 3: Stress-Test the Plan, Not Just the Brochure
Ask whether the next step should be timed intercourse, letrozole, IUI, or IVF; whether an antagonist protocol fits a high-responder PCOS picture; or whether freeze-all is being chosen for OHSS risk, elevated progesterone, or PGT logistics. Compare the recommendation with professional-society positions rather than forum consensus.
| What you are often given | What you can walk in with |
|---|---|
| A lab flag of “low” or “normal” | Age-contextual meaning and what it changes in a protocol |
| A standard three-IUI package | When IUI still makes sense — and when it is buying delay |
| An add-on menu (glue, scratch, immunology, PRP) | HFEA-style evidence questions to ask before you pay |
| Raw SART/HFEA percentages | Patient-mix caveats and what your diagnosis does to those averages |
| A new protocol after a failed cycle | A structured post-mortem: response, embryo quality, or implantation? |
"Clinic quoted EmbryoGlue, endometrial scratch, and PGT-A on a first IVF cycle at 32 with unexplained infertility. Which of these has evidence for someone like me, and what should I ask before consenting?"
Step 4: Prepare the Appointment You Actually Get
Most consults are short. Turn the analysis into a one-page question list: trigger criteria, progesterone threshold for freeze-all, ICSI indications, PGT-M vs. PGT-A, medication estimates vs. à la carte fees, and what happens if fewer than X mature eggs are retrieved. You leave with decisions, not a fog of acronyms.
"I have a monitoring visit tomorrow. Lead follicle 16 mm, E2 1,850, 11 follicles over 12 mm on antagonist. Write the questions I should ask about trigger timing and OHSS prevention."
Step 5: Stay Oriented Across Cycles
After retrieval, fertilization report, or a beta, come back with the new data. Persistent memory means the next conversation already knows last cycle’s dose, the premature progesterone rise, and that you declined IVIG. That continuity is the difference between repeating Google and building a treatment record you can actually use.
Try it free — no credit card required — and bring the last result you have not had time to unpack.
Results & Use Cases
📊 Making Sense of a First Fertility Workup
Scenario: You are 35, trying for seven months, and a primary-care panel just returned AMH 1.4 ng/mL and TSH 3.1. Your portal says “see specialist.” You have 11 days until the RE consult and a head full of worst-case searches.
Traditional Approach: Hours on forums that collapse ovarian reserve into destiny, plus a consult where you are still learning what AFC is while the plan is already being written.
Fertility & IVF Advisor: You get a plain-language read: AMH in this range at 35 is not a diagnosis of infertility; TSH may need a tighter preconception target depending on current guidance; and the evidence-based clock for evaluation is typically 6 months at 35+, sooner with red flags. You arrive with a workup checklist (AFC, semen analysis, tubal assessment) instead of a panic spiral.
- Separates quantity markers from quality and age
- Distinguishes “repeat this test” from “this changes the ladder”
- Turns a first visit into a collaboration, not a lecture
💼 Auditing an IVF Add-On and Protocol Quote
Scenario: You are 41 with diminished reserve. The clinic recommends a high-dose antagonist cycle, PGT-A on any blasts, calcium ionophore, and intrauterine PRP. The quote is one cycle of hope plus four line items you cannot evaluate.
Traditional Approach: Either accept the bundle because you do not want to seem difficult, or refuse everything and worry you left success on the table.
With personalized IVF analysis: You get a structured evidence map. ASRM’s PGT-A committee opinion is more relevant at 41 than at 32, but it still does not make PGT a magic cumulative-success machine — and ACOG’s PGT guidance is clear that aneuploidy screening is not the same as testing for a known single-gene condition (PGT-M). Polygenic embryo screening (PGT-P) is not ready for clinical use, per ASRM ethics and practice committees. PRP sits on the HFEA add-ons list because evidence that it improves the chance of a baby is limited and safety questions remain. You keep PGT-A as a discussion about embryo-to-uterus ratio, not as a default upsell.
- Frames cost as cumulative chance per live birth, not per extra vial
- Helps you challenge one-size-fits-all protocols without attacking your RE
- Distinguishes “offered to everyone” from “indicated for you”
📱 The Two-Week Wait, on Your Phone at 11 p.m.
Scenario: Day 7 post-transfer. You have cramping, a tiny bit of spotting, and progesterone oil in the fridge. Every symptom is a Rorschach test. You are not going to reach the nurse line until morning, and you are on the couch on your phone.
Traditional Approach: Symptom googling, which cannot distinguish luteal-support side effects from implantation, followed by a night of catastrophic certainty.
On mobile: You get an honest briefing: breast tenderness, cramping, and spotting are ambiguous; progesterone levels on supplementation reflect the medication, not pregnancy; the only reliable early indicator is the scheduled beta. Thresholds are specific — what “low” vs. “cautiously positive” vs. “reassuring” typically means after a blastocyst transfer — without pretending a symptom is a test.
If the wait, a negative beta, or a chemical pregnancy is pulling you under, Personal Therapist can sit with the grief and anxiety in parallel, which is often what the 2 a.m. spiral actually needs.
- Works on iOS and Android with the same history as desktop
- Replaces false symptom reading with test-day thresholds
- Knows when to stop reassuring and name a real loss
If treatment works and you suddenly need feeding, sleep, and newborn logistics instead of stim calendars, Parenting & Baby Advisor picks up the next chapter — including the cautious-hope hangover that does not end with a positive test.
FAQ
Is Fertility & IVF Advisor free?
You can start on a free plan with core features and limited monthly usage. Paid tiers increase usage if you are in a heavy cycle of monitoring, protocol reviews, and appointment prep. There is no requirement to buy a clinic package or add-on to ask a first question.
Does this AI fertility advisor replace my reproductive endocrinologist?
No. It is not a licensed physician and it does not diagnose, prescribe, or manage your cycle. It helps you understand results, compare options with published evidence, and show up to medical visits with better questions. Treatment changes still belong with your RE, and emergency symptoms (severe OHSS signs, heavy bleeding, one-sided pain) belong in urgent clinical care, not in a chat.
Can it interpret AMH, semen analysis, and IVF monitoring labs?
Yes. That is a core use. It will contextualize AMH and AFC as response predictors, explain why one semen analysis is not a diagnosis, and walk through follicle-growth and estradiol patterns during stimulation. It will also say when a number is not enough — for example, when day-3 estradiol is high enough to invalidate FSH, or when morphology catastrophizing is out of proportion to the evidence.
How is this different from a general chatbot or my clinic portal?
Clinic portals store values; general chatbots do not reliably track your last three cycles or current society positions on add-ons. This advisor is built around reproductive endocrinology workflows: protocol phenotypes, trigger choice, luteal support, PGT distinctions, and the financial and emotional constraints that actually decide whether a plan is feasible. It remembers your history, and it is designed to cite professional sources rather than recycle forum certainty.
Does Fertility & IVF Advisor work on mobile?
Yes. It is available on web, iOS, and Android with synced history, which matters when monitoring instructions change the same afternoon or a beta result lands after hours. Speech-to-text is useful when your hands are full of syringes and printouts.
Can it help me decide about PGT-A, donor eggs, or stopping treatment?
It can map trade-offs with current evidence and your stated values. For PGT-A, that includes the difference between per-transfer implantation and cumulative live birth, and the stronger observational signal at older ages versus the lack of proof as universal screening. Donor eggs and stopping are framed as autonomous path changes, not failures — and it will not push either unprompted. When the question is “should I stop,” it stays with you rather than rushing a clinical next step.
Walk Into the Next Visit With a Plan
Fertility care asks you to be a patient, a project manager, and a financial analyst at the same time — often while you are grieving a version of conception you were told would be simple. Labs without context, add-ons without evidence, and 15-minute visits are a poor match for decisions that can cost a large share of a year’s disposable income.
An AI fertility advisor does not make those facts kinder. It makes them usable: what this AMH means at your age, whether another IUI is still a reasonable bet, which extras the HFEA would not call proven, and which questions will actually change the plan.
Bring the last result you do not fully understand. Try Fertility & IVF Advisor now. Explore more at Jenova.
For Developers: Fertility & IVF Advisor is available programmatically via the Jenova API — integrate personalized fertility analysis and IVF cycle guidance into your application with a single API call. Full documentation →